- Home
- AEIS vs AXSM Comparison
AEIS vs AXSM Comparison
Compare AEIS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEIS
- AXSM
- Stock Information
- Founded
- AEIS 1981
- AXSM 2012
- Country
- AEIS United States
- AXSM United States
- Employees
- AEIS N/A
- AXSM N/A
- Industry
- AEIS Industrial Machinery/Components
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- AEIS Technology
- AXSM Health Care
- Exchange
- AEIS Nasdaq
- AXSM Nasdaq
- Market Cap
- AEIS 4.7B
- AXSM 5.1B
- IPO Year
- AEIS 1995
- AXSM 2015
- Fundamental
- Price
- AEIS $150.82
- AXSM $104.80
- Analyst Decision
- AEIS Buy
- AXSM Strong Buy
- Analyst Count
- AEIS 9
- AXSM 16
- Target Price
- AEIS $136.33
- AXSM $176.56
- AVG Volume (30 Days)
- AEIS 386.1K
- AXSM 645.4K
- Earning Date
- AEIS 08-05-2025
- AXSM 08-04-2025
- Dividend Yield
- AEIS 0.27%
- AXSM N/A
- EPS Growth
- AEIS N/A
- AXSM N/A
- EPS
- AEIS 2.22
- AXSM N/A
- Revenue
- AEIS $1,635,742,000.00
- AXSM $495,033,000.00
- Revenue This Year
- AEIS $15.58
- AXSM $61.62
- Revenue Next Year
- AEIS $7.71
- AXSM $59.02
- P/E Ratio
- AEIS $67.99
- AXSM N/A
- Revenue Growth
- AEIS 8.49
- AXSM 69.83
- 52 Week Low
- AEIS $75.01
- AXSM $75.56
- 52 Week High
- AEIS $152.23
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- AEIS 67.69
- AXSM 49.53
- Support Level
- AEIS $128.40
- AXSM $101.11
- Resistance Level
- AEIS $145.21
- AXSM $109.88
- Average True Range (ATR)
- AEIS 4.70
- AXSM 4.29
- MACD
- AEIS 0.11
- AXSM 0.06
- Stochastic Oscillator
- AEIS 94.08
- AXSM 61.77
About AEIS Advanced Energy Industries Inc.
Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.